tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
ANNX
Annexon Biosciences
RESEARCH TOOLSreports

Annexon Biosciences (ANNX) Stock Forecast & Price Target

Compare
1,391 Followers
See the Price Targets and Ratings of:

ANNX Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Annexon
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ANNX Stock 12 Month Forecast

Average Price Target

$11.00
▲(120.00% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Annexon Biosciences in the last 3 months. The average price target is $11.00 with a high forecast of $14.00 and a low forecast of $8.00. The average price target represents a 120.00% change from the last price of $5.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","15":"$15","3.75":"$3.75","7.5":"$7.5","11.25":"$11.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,3.75,7.5,11.25,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jul<br/>2025","9":"Nov<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.52,6.172307692307692,6.8246153846153845,7.476923076923077,8.12923076923077,8.781538461538462,9.433846153846154,10.086153846153845,10.73846153846154,11.39076923076923,12.043076923076924,12.695384615384615,13.347692307692308,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.52,5.941538461538461,6.363076923076923,6.7846153846153845,7.206153846153846,7.627692307692307,8.04923076923077,8.47076923076923,8.892307692307693,9.313846153846153,9.735384615384614,10.156923076923077,10.57846153846154,{"y":11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.52,5.71076923076923,5.901538461538461,6.092307692307692,6.283076923076923,6.473846153846154,6.664615384615384,6.855384615384615,7.046153846153846,7.236923076923077,7.427692307692308,7.618461538461538,7.809230769230769,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.28,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.13,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.07,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.02,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$14.00Average Price Target$11.00Lowest Price Target$8.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ANNX
Ananda Ghosh
H.C. Wainwright
H.C. Wainwright
$14
Buy
180.00%
Upside
Reiterated
03/20/26
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (NASDAQ: ANNX) and Electrocore (NASDAQ: ECOR)
Needham Analyst forecast on ANNX
Joseph Stringer
Needham
Needham
$11
Buy
120.00%
Upside
Assigned
03/19/26
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
Bank of America Securities Analyst forecast on ANNX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$8
Buy
60.00%
Upside
Reiterated
03/19/26
Bank of America Securities Keeps Their Buy Rating on Annexon Biosciences (ANNX)
J.P. Morgan Analyst forecast on ANNX
Anupam Rama
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/18/26
Analysts Conflicted on These Healthcare Names: Trevi Therapeutics (NASDAQ: TRVI), Annexon Biosciences (NASDAQ: ANNX) and Medtronic (NYSE: MDT)
TD Cowen Analyst forecast on ANNX
Phil Nadeau
TD Cowen
TD Cowen
―
Buy
―
Reiterated
01/13/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Amgen (NASDAQ: AMGN) and Annexon Biosciences (NASDAQ: ANNX)
Chardan Capital Analyst forecast on ANNX
Daniil Gataulin
Chardan Capital
Chardan Capital
$16
Buy
220.00%
Upside
Initiated
12/23/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Annexon Biosciences (NASDAQ: ANNX)
Wells Fargo Analyst forecast on ANNX
Derek Archila
Wells Fargo
Wells Fargo
$27
Buy
440.00%
Upside
Reiterated
12/16/25
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Novan (NOVN)
Clear Street Analyst forecast on ANNX
William Maughan
Clear Street
Clear Street
$17
Buy
240.00%
Upside
Initiated
12/01/25
Annexon initiated with a Buy at Clear StreetAnnexon initiated with a Buy at Clear Street
Jefferies Analyst forecast on ANNX
Andrew Tsai
Jefferies
Jefferies
$10
Buy
100.00%
Upside
Reiterated
11/11/25
Annexon Biosciences (ANNX) Gets a Buy from Jefferies
Cantor Fitzgerald Analyst forecast on ANNX
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
05/13/25
Cantor Fitzgerald reiterates Overweight Rating on Annexon Biosciences (ANNX)Cantor Fitzgerald analyst Pete Stavropoulos reiterated an Overweight rating on Annexon Biosciences (NASDAQ: ANNX).
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ANNX
Ananda Ghosh
H.C. Wainwright
H.C. Wainwright
$14
Buy
180.00%
Upside
Reiterated
03/20/26
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (NASDAQ: ANNX) and Electrocore (NASDAQ: ECOR)
Needham Analyst forecast on ANNX
Joseph Stringer
Needham
Needham
$11
Buy
120.00%
Upside
Assigned
03/19/26
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
Bank of America Securities Analyst forecast on ANNX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$8
Buy
60.00%
Upside
Reiterated
03/19/26
Bank of America Securities Keeps Their Buy Rating on Annexon Biosciences (ANNX)
J.P. Morgan Analyst forecast on ANNX
Anupam Rama
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/18/26
Analysts Conflicted on These Healthcare Names: Trevi Therapeutics (NASDAQ: TRVI), Annexon Biosciences (NASDAQ: ANNX) and Medtronic (NYSE: MDT)
TD Cowen Analyst forecast on ANNX
Phil Nadeau
TD Cowen
TD Cowen
―
Buy
―
Reiterated
01/13/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Amgen (NASDAQ: AMGN) and Annexon Biosciences (NASDAQ: ANNX)
Chardan Capital Analyst forecast on ANNX
Daniil Gataulin
Chardan Capital
Chardan Capital
$16
Buy
220.00%
Upside
Initiated
12/23/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Annexon Biosciences (NASDAQ: ANNX)
Wells Fargo Analyst forecast on ANNX
Derek Archila
Wells Fargo
Wells Fargo
$27
Buy
440.00%
Upside
Reiterated
12/16/25
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Novan (NOVN)
Clear Street Analyst forecast on ANNX
William Maughan
Clear Street
Clear Street
$17
Buy
240.00%
Upside
Initiated
12/01/25
Annexon initiated with a Buy at Clear StreetAnnexon initiated with a Buy at Clear Street
Jefferies Analyst forecast on ANNX
Andrew Tsai
Jefferies
Jefferies
$10
Buy
100.00%
Upside
Reiterated
11/11/25
Annexon Biosciences (ANNX) Gets a Buy from Jefferies
Cantor Fitzgerald Analyst forecast on ANNX
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
05/13/25
Cantor Fitzgerald reiterates Overweight Rating on Annexon Biosciences (ANNX)Cantor Fitzgerald analyst Pete Stavropoulos reiterated an Overweight rating on Annexon Biosciences (NASDAQ: ANNX).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Annexon Biosciences

3 Months
xxx
Success Rate
8/14 ratings generated profit
57%
Average Return
+11.59%
reiterated a xxx
 rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +11.59% per trade.
1 Year
Tazeen AhmadBank of America Securities
Success Rate
7/12 ratings generated profit
58%
Average Return
+42.40%
reiterated a buy rating 10 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +42.40% per trade.
2 Years
xxx
Success Rate
11/16 ratings generated profit
69%
Average Return
+45.79%
reiterated a xxx
 rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +45.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ANNX Analyst Recommendation Trends

Rating
Sep 25
Nov 25
Dec 25
Jan 26
Mar 26
Strong Buy
7
11
9
8
5
Buy
1
2
1
5
6
Hold
0
0
1
36
36
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
13
11
49
47
In the current month, ANNX has received 11 Buy Ratings, 36 Hold Ratings, and 0 Sell Ratings. ANNX average Analyst price target in the past 3 months is 11.00.
Each month's total comprises the sum of three months' worth of ratings.

ANNX Financial Forecast

ANNX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

ANNX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

ANNX Stock Forecast FAQ

What is ANNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Annexon Biosciences’s 12-month average price target is 11.00.
    What is ANNX’s upside potential, based on the analysts’ average price target?
    Annexon Biosciences has 120.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ANNX a Buy, Sell or Hold?
          Annexon Biosciences has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Annexon Biosciences’s price target?
            The average price target for Annexon Biosciences is 11.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $14.00 ,the lowest forecast is $8.00. The average price target represents 120.00% Increase from the current price of $5.
              What do analysts say about Annexon Biosciences?
              Annexon Biosciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of ANNX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.